1. King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet. 2005; 365 (9470):
1561.
2. Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006; 368 (9541): 1106.
3. Buonfrate D, Ferrari TCA, Adegnika AA, Russel Stothard J, Gobbi FG. Human schistosomiasis. Lancet. 2025;405(10479):658-670.
4. Buonfrate D, Tamarozzi F, Gobbi F. Schistosomiasis in returning travellers and migrants: gaps and research priorities. J travel Med. 2023;30(7):taad118.
5. Coutinho HM, Acosta LP, Wu HW, McGarvey ST, Su L, Langdon GC, et al. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. J Infect
Dis. 2007; 195 (2): 288.
6. Iriarte C, Marks DH. Cutaneous schisosomiasis: epidemiological and clinical characteristics in returning travelers. Int J Dermatol. 2023 Mar; 62 (3): 376-386.
7. Bottieau E, Clerinx J, De Vega MR, Den Enden EV, Colebunders R, Van Esbroeck M, et al. Imported Katayama fever: clinical and biological features at presentation and during treatment. J
Infect 2006; 52: 339–45.
8. Kara M, Sozubir S. Urinary schistosomiasis. N Engl J Med. 2023 Aug 3; 389 (5): 454.
9. Andrade ZA. Schistosomiasis and hepatic fibrosis regression. Acta Trop. 2008 Nov-Dec; 108 (2-3): 79-82.
10. Bobrovski VG, Pinheiro AL, De-Castro JAL, Rech EB, Zacarkim EV, Dos-S-Reis ES, et al. Schistosomiasis: A neglected cause of pulmonary arterial hypertension in Brazil. Curr Probl Cardiol.
2024 Mar; 49 (3): 102340.
11. Hotez PJ, Engels D, Gyapong M, Ducker C, Malecela MN. Female genital schistosomiasis. N Engl J Med. 2019 Dec 26; 381 (26): 2493-2495.
12. Zaqout A, Abid FB, Murshed K, Al-Bozom I, Al-Rumaihi G, Soub HA, et al. Cerebral schistosomiasis: Cse series from Qatar. Int J Infect Dis. 2019 Sep: 86: 167-170.
13. Fritzsche, C, Stachs O, Holtfreter MC, Nohr-Luczak C, Guthoff RF, Reisinger EC. Confocal laser scanning microscopy, a new in vivo diagnostic tool for schistosomiasis. PLoS ONE 7, e34869
(2012).
14. Grenfell RFQ, Taboada D, Coutinho LA, Pedrosa MLC, Assis JV, Oliveira MSP, et al. Innovative methodology for point-of-care circulating cathodic antigen with rapid urine concentration for
use in the field for detecting low Schistosoma mansoni infection and for control of cure with high accuracy. Trans. R. Soc. Trop. Med. Hyg. 112, 1–7 (2018).
15. Cnops L, Tannich E, Polman K, Clerinx J, Van Esbroeck M. Schistosoma real-time PCR as diagnostic tool for international travellers and migrants. Trop. Med. Int. Health 17, 1208–1216
(2012).
16. Hinz R, Schwarz NG, Hahn A, Frickmann H. Serological approaches fort he diagnosis of schistosomiasis – A review. Mol Cel Probes. 2017 Feb: 31: 2-21.
17. Monnier N, Barth-Jaeggi T, Knopp S, Steinmann P. Core components, concepts and strategies for parasitic and vector-borne disease elimination with a focus on schistosomiasis: A landscape
analysis. PloS Negl Trop Dis. 2020; 14 (10): e0008837.
18. Jauréguiberry S, Paris L, Caumes E. Acute schistosomiasis, a diagnostic and therapeutic challenge. Clin Microbiol Infect. 2010;16(3):225.
19. Tukahebwa EM, Vennervald BJ, Nuwaha F, Kabatereine NB, Magnussen P. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and
re-infection in Mayuge District, Uganda. Trans R Soc Trop Med Hyg. 2013; 107 (6): 397.
20. Danso-Appiah A, Olliaro PL, Donegan S, Sinclair D, Utzinger J. Drugs for treating Schistosoma mansoni infection. Cochrane Database Syst Rev. 2013.
21. Centers for Disease Control and Prevention. Parasites – schistosmiasis. Available from http:/www.cdc.gov/parasites/schistosmiasis/ Accessed January 24, 2014.
22. Stothard JR, Figueiredo JC, Navaratnam AM. Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis. Expert Rev Anti Infect
Ther. 2013:11(7): 733–752.
23. Mas-Coma S. Epidemiology of fascioliasis in human endemic areas. J Helminthol. 2005; 79 (3): 207.
24. Mas-Coma S, Valero MA, Bargues MD. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemi-
ology and control. Adv Parasitol. 2009; 69:41.
25. Siles-Lucas M, Becerro-Recio D, Serrat J, Gonzalez-Miguel J. Fascioliasis and fasciolopsiasis: Current knowledge and future trends. Res Vet Sci. 2021 Jan: 134: 27-35.
26. Khalil G, Haddad C, Otrock ZK, Jaber F, Farra A. Halzoun, an allergic pharyngitis syndrome in Lebanon: the trematode Dicrocoelium dendriticum as an additional cause. Acta Trop. 2013;
125 (1): 115.
27. Mirzadeh A, Jafarihaghighi F, Kazemirad E, Sabzevar SS, Tanipour MH, Ardjmand M. Recent Developments in Recombinant Proteins for Diagnosis of Human Fascioliasis. Acta Parasitol.
2021; 66 (1): 13.
28. Shin SH, Hsu A, Chastain HM, Cruz LA, Elder ES, Sapp SG, et al. Development of Two FhSAP2 Recombinant-Based Assays for Immunodiagnosis of Human Chronic Fascioliasis. Am J Trop
Med Hyg. 2016; 95 (4): 852.
29. Marcos LA, Tagle M, Terashima A, Bussalleu A, Ramirez C, Carrasco C, Valdez L, Huerta-Mercado J, Freedman DO, Vinetz JM, Gotuzzo E. Natural history, clinicoradiologic correlates, and
response to triclabendazole in acute massive fascioliasis. Am J Trop Med Hyg. 2008;78(2):222.
30. Angles R, Buchon P, Valero MA, Bargues MD, Mas-Coma S. One Health Action against Human Fascioliasis in the Bolivian Altiplano: Food, Water, Housing, Behavioural Traditions, Social
Aspects, and Livestock Management Linked to Disease Transmission and Infection Sources. Int J Environ Res Public Health. 2022; 19 (3)
31. Kueakhai P, Chaithirayanon, Chaiwichien A, Samrit T, Osotprasit S, Suksomboon P, et al. Monoclonal antibody against Fasciola gigantica glutathione peroxidase and their immunodiagnosis
potential for fasciolosis. Vet Parasitol. 2019 Dec: 276: 108979.
32. Sadaow L, Yamasaki H, Morishima Y, Sanpool O, Rodpai R, Janwan P, et al. Effectiveness of Fasciola gigantica excretory-secretory and recombinant cathepsin L antigens for rapid diagnosis of
human fascioliasis using immunochromatographic devices. Parasitol Res. 2020; 119 (11): 3691.
33. Cabeza-Barrera I, Cabezas-Fernández T, Salas Coronas J, Vázquez Villegas J, Cobo F. Dicrocoelium dendriticum: an emerging spurious infection in a geographic area with a high level of immigra-
tion. Ann Trop Med Parasitol. 2011; 105: 403–406.
34. Moure Z, Zarzuela F, Espasa M, Pou D, Serre-Delcor N, Trevino B, Bocanegra C, Molina I, Pumarola T, Sulleiro E. Dicrocoelium dentriticum: An Unusual Parasitological Diagnosis in a
Reference International Health Unit. Am J Trop Med Hyg. 2017;96(2):355-357.
35. Cabeza-Barrera I, Cabezas-Fernández T, Vázquez-Villegas J, Salas-Corona J. Dolor abdominal en una paciente de origen magrebí Enferm Infecc Microbiol Clin. 2007; 25: 213–214.
36. Qian MB, Utzinger J, Keiser J, Zhou XN. Clonorchiasis. Lancet. 2016; 387 (10020): 800.
37. Pakharukova MY, Mordvinov VA. The liver fluke Opisthorchis felineus: biology, epidemiology and carcinogenic potential. Trans R Soc Trop Med Hyg. 2016; 110 (1): 28.
38. Na BK, Pak JH, Hong SJ. Clonorchis sinensis and clonorchiasis. Acta Trop. 2020 Mar: 203: 105309.
39. Sadaow L, Sanpool O, Rodpai R, Yamasaki H, Ittiprasert W, Mann VH, et al. Development of an Immunochromatographic Point-of-Care Test for Serodiagnosis of Opisthorchiasis and Clo-
norchiasis. Am J Trop Med Hyg. 2019; 101 (5): 1156.
40. Worasith C, Wangboon C, Duenngai K, Kiatsopit N, Kopolrat K, Techasen A, et al. Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini
infection in communities with different transmission levels in Northeast Thailand. PLoS Negl Trop Dis. 2019; 13 (2): e0007186.
41. Saijuntha W, Sithithaworn P, Petney TN, Andrews RH. Foodborne zoonotic parasites of the family Opisthorchiidae. Res Vet Sci. 2021; 135: 404.
42. Saengsawang P, Promthet S, Bradshaw P. Infection with Opisthorchis viverrini and use of praziquantel among a working-age population in northeast Thailand. Asian Pac J Cancer Prev.
2013;14(5):2963-6.
43. Worasith C, Wangboon C, Kopolrat KY, Homwong C, Sithithaworn J, Techasen A, Thanan R, Khuntikeo N, Sithithaworn P. Application of urine antigen assay to evaluate outcomes of pra-
ziquantel treatment and reinfection in opsthorchiasis in northeast Thailand. Trans R Soc Trop Med Hyg. 2020;114(10):751.
44. Singh TS, Sugiyama H, Rangsiruji A. Paragonimus & paragonimiasis in India. Indian J Med Res. 2012;136(2):192-204.
45. Blair D. Paragonimiasis. Adv Exp Med Biol. 2019;1154:105.
46. Ahn CS, Shin JW, Kim JG, Lee WY, Kang I, Im JG, Kong Y. Spectrum od pleurapulmonary paragonimiasis: An analysis of 685 cases diagnosed over 22 years. J Infect. 2021;82(1):150.
47. Curtis KC, Fischer K, Choi YJ, Mitreva M, Weil GJ, Fisher PU. Characterization and localization of antigens for serodiagnosisof human paragonimiasis. Parasitol Res. 2021;120(2);535.